127 related articles for article (PubMed ID: 7428635)
1. [Therapy of chronic heart failure in old age].
Polzien P; Polzien E
Dtsch Med Wochenschr; 1980 Aug; 105(35):1201-2. PubMed ID: 7428635
[No Abstract] [Full Text] [Related]
2. [Modifying factors in carciac glycoside therapy].
Krebs R
Med Klin; 1976 Oct; 71(42):1759-70. PubMed ID: 790134
[No Abstract] [Full Text] [Related]
3. [Treatment of heart failure, with special consideration of iatrogenic complications].
Lüderitz B; Avenhaus H
Munch Med Wochenschr; 1970 Oct; 112(40):1779-84. PubMed ID: 5536213
[No Abstract] [Full Text] [Related]
4. [Quantitative therapy with cardiac glycosides].
Storz H
Med Welt; 1966 Aug; 35():1802-8. PubMed ID: 5975346
[No Abstract] [Full Text] [Related]
5. [Optimization of therapy using cardiac glycosides].
Ziesenhenn K; Behn P
Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac glycoside therapy of congestive heart failure. II].
Tomov I
Vutr Boles; 1981; 20(1):1-9. PubMed ID: 7245720
[No Abstract] [Full Text] [Related]
7. [Intravenous proscillaridin A in cardiotonic therapy of the senile heart].
Massoni G
G Gerontol; 1968 Sep; 16(9):975-8. PubMed ID: 5754030
[No Abstract] [Full Text] [Related]
8. [Certain problems of tactics in digitalis therapy].
Votchal BE; Kkvoĭnitskaia OL
Klin Med (Mosk); 1974 Mar; 52(3):22-5. PubMed ID: 4466942
[No Abstract] [Full Text] [Related]
9. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
Gold H; Kwit NT; Shane SJ; Dayrit C
J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
[No Abstract] [Full Text] [Related]
10. [Cardiac glycoside therapy].
Born H
Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723
[No Abstract] [Full Text] [Related]
11. [Cardiac glycoside therapy].
Michel D
Fortschr Med; 1971 Aug; 89(24):917-21. PubMed ID: 4262966
[No Abstract] [Full Text] [Related]
12. [Diagnosis and treatment of heart failure from the viewpoint of general practice].
Böhm C
Z Allgemeinmed; 1972 Mar; 48(9):422-4. PubMed ID: 5034159
[No Abstract] [Full Text] [Related]
13. [Cardiac dynamics-quotient and glycoside therapy].
Gutschker A
Dtsch Gesundheitsw; 1970 Aug; 25(32):1515-6. PubMed ID: 5509390
[No Abstract] [Full Text] [Related]
14. [Clinical trial of a new cardiac glycoside: cd.412].
Gentile C; Gentile JH
Prensa Med Argent; 1972 Jun; 59(22):841-8. PubMed ID: 5051118
[No Abstract] [Full Text] [Related]
15. [Directed glycoside therapy of manifest heart insufficiency].
Storz H
Med Klin; 1971 Apr; 66(16):587-92. PubMed ID: 5552925
[No Abstract] [Full Text] [Related]
16. [Problems in intramural and ambulatory drug therapy of heart insufficiency following myocardial infarct].
Schaller K
Z Gesamte Inn Med; 1990 Jul; 45(14):429-30. PubMed ID: 2293517
[TBL] [Abstract][Full Text] [Related]
17. [The quantitative aspect of therapy using cardiac glycosides].
Slutskiĭ ME; Votchal BE
Vestn Akad Med Nauk SSSR; 1967; 22(4):57-64. PubMed ID: 5608374
[No Abstract] [Full Text] [Related]
18. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
Denisiuk VI; Shkliar MB
Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
[No Abstract] [Full Text] [Related]
19. [Quantitative studies on the therapeutic range of cardiac glycosides].
Diederen W; Kadatz R
Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
[No Abstract] [Full Text] [Related]
20. [Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].
Bojorges R; Cárdenas M; Pastelín G; Mendez R
Arch Inst Cardiol Mex; 1974; 44(4):615-23. PubMed ID: 4847978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
